Abstract
Fetal hemoglobin (HbF, α2γ2) is a major contributor to the remarkable phenotypic heterogeneity of sickle cell anemia (SCA). Genetic variation at 3 principal loci (HBB cluster on chromosome 11p, HBS1L-MYB region on chromosome 6q, and BCL11A on chromosome 2p) have been shown to influence HbF levels and disease severity in β-thalassemia and SCA. Previous studies in SCA, however, have been restricted to populations from the African diaspora, which include multiple genealogies.We have investigated the influence of these 3 loci on HbF levels in sickle cell patients from Tanzania and in a small group of African British sickle patients. All 3 loci have a significant impact on the trait in both patient groups. The results suggest the presence of HBS1L-MYB variants affecting HbF in patients who are not tracked well by European-derived markers, such as rs9399137. Additional loci may be identified through independent genome-wide association studies in African populations. © 2011 by The American Society of Hematology.
Cite
CITATION STYLE
Makani, J., Menzel, S., Nkya, S., Cox, S. E., Drasar, E., Soka, D., … Thein, S. L. (2011). Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood, 117(4), 1390–1392. https://doi.org/10.1182/blood-2010-08-302703
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.